Research ArticleOriginal Article
Open Access

Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia

Areej I. Alshayea, Gamal E. Eid, Malak M. El-Hazmi and Abdulkarim F. Alhetheel
Saudi Medical Journal October 2016, 37 (10) 1114-1119; DOI: https://doi.org/10.15537/smj.2016.10.14705

References

  1. ↵
    1. Liang TJ
    (2009) Hepatitis B: the virus and disease. Hepatology 49:S13–S21.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Franco E,
    2. Bagnato B,
    3. Marino MG,
    4. Meleleo C,
    5. Serino L,
    6. Zaratti L,
    7. Hepatitis B
    (2012) Epidemiology and prevention in developing countries. World J Hepatol 4:74–80.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Thiers V,
    2. Nakajima E,
    3. Kremsdorf D,
    4. Mack D,
    5. Schellekens H,
    6. Driss F,
    7. et al.
    (1988) Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 2:1273–1276.
    OpenUrlPubMedWeb of Science
  4. ↵
    1. Andre F
    (2000) Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18:S20–S22.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Williams R
    (2006) Global challenges in liver disease. Hepatology 44:521–526.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Memish ZA,
    2. Knawy BA,
    3. El-Saed A
    (2010) Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis 14:e115–e120.
    OpenUrlPubMed
    1. Al-Tawfiq JA,
    2. Anani A
    (2008) Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital. Med Sci Monit 14:CR52–CR56.
    OpenUrlPubMed
  8. ↵
    1. Alshabanat AA,
    2. Albacker RB,
    3. Basalama AA,
    4. Bin Salamah AA,
    5. SalehAlfrayh A
    (2013) Profile of viral hepatits in Saudi Arabia. Biomed Res 24:396–399.
    OpenUrl
  9. ↵
    1. Raimondo G,
    2. Pollicino T,
    3. Romano L,
    4. Zanetti AR
    (2010) A 2010 update on occult hepatitis B infection. Pathol Biol (Paris) 58:254–257.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Kwak MS,
    2. Kim YJ
    (2014) Occult hepatitis B virus infection. World J Hepatol 6:860–869.
    OpenUrl
  11. ↵
    1. Behzad-Behbahani A,
    2. Mafi-Nejad A,
    3. Tabei SZ,
    4. Lankarani KB,
    5. Torab A,
    6. Moaddeb A
    (2006) Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 123:37–42.
    OpenUrlPubMed
    1. Bhatti FA,
    2. Ullah Z,
    3. Salamat N,
    4. Ayub M,
    5. Ghani E
    (2007) Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 47:74–79.
    OpenUrl
  13. ↵
    1. Ramia S,
    2. Ramlawi F,
    3. Kanaan M,
    4. Klayme S,
    5. Naman R
    (2005) Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiol Infect 133:695–699.
    OpenUrlPubMed
  14. ↵
    1. Ismail AM,
    2. Devakumar S,
    3. Anantharam R,
    4. Fletcher GJ,
    5. Subramani T,
    6. John GT,
    7. et al.
    (2012) Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus 10:230–232.
    OpenUrlPubMed
  15. ↵
    1. Jeantet D,
    2. Chemin I,
    3. Mandrand B,
    4. Tran A,
    5. Zoulim F,
    6. Merle P,
    7. et al.
    (2004) Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 73:508–515.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Garfein RS,
    2. Bower WA,
    3. Loney CM,
    4. Hutin YJ,
    5. Xia GL,
    6. Jawanda J,
    7. et al.
    (2004) Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 40:865–873.
    OpenUrlPubMedWeb of Science
  17. ↵
    1. Chevaliez S,
    2. Bouvier-Alias M,
    3. Laperche S,
    4. Hezode C,
    5. Pawlotsky JM
    (2010) Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification. J Clin Microbiol 48:3641–3647.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Osiowy C,
    2. Giles E
    (2003) Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype. J Clin Microbiol 41:5473–5477.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. El-Hazmi MM
    (2004) Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 25:26–33.
    OpenUrlPubMedWeb of Science
  20. ↵
    1. Mujeeb SA,
    2. Aamir K,
    3. Mehmood K
    (2006) Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc 56:S24–S25.
    OpenUrlPubMed
  21. ↵
    1. Seo DH,
    2. Whang DH,
    3. Song EY,
    4. Kim HS,
    5. Park Q
    (2011) Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion 51:1840–1846.
    OpenUrlCrossRef
  22. ↵
    1. Manzini P,
    2. Girotto M,
    3. Borsotti R,
    4. Giachino O,
    5. Guaschino R,
    6. Lanteri M,
    7. et al.
    (2007) Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 92:1664–1670.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Bernvil SS,
    2. Andrews V,
    3. Kuhns MC,
    4. McNamara AL
    (1997) Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 18:49–53.
    OpenUrlPubMed
  24. ↵
    1. Abdo AA,
    2. Al-Jarallah BM,
    3. Sanai FM,
    4. Hersi AS,
    5. Al-Swat K,
    6. Azzam NA,
    7. Al-Dukhayil M,
    8. et al.
    (2006) Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 12:7019–7024.
    OpenUrlPubMed
  25. ↵
    1. Kleinman SH,
    2. Kuhns MC,
    3. Todd DS,
    4. Glynn SA,
    5. McNamara A,
    6. DiMarco A,
    7. et al.
    (2003) Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 43:696–704.
    OpenUrl
  26. ↵
    1. Allain JP,
    2. Candotti D,
    3. Soldan K,
    4. Sarkodie F,
    5. Phelps B,
    6. Giachetti C,
    7. et al.
    (2003) The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101:2419–2425.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Hennig H,
    2. Puchta I,
    3. Luhm J,
    4. Schlenke P,
    5. Goerg S,
    6. Kirchner H
    (2002) Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 100:2637–2641.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Zervou EK,
    2. Dalekos GN,
    3. Boumba DS,
    4. Tsianos EV
    (2001) Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 41:652–658.
    OpenUrl
    1. Wolff FH,
    2. Fuchs SC,
    3. Brandao AB
    (2011) Absence of occult hepatitis B among blood donors in southern Brazil. Braz J Infect Dis 15:159–162.
    OpenUrlPubMed
  30. ↵
    1. Sofian M,
    2. Aghakhani A,
    3. Izadi N,
    4. Banifazl M,
    5. Kalantar E,
    6. Eslamifar A,
    7. et al.
    (2010) Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 14:e308–e310.
    OpenUrlPubMed
  31. ↵
    1. Silva CM,
    2. Costi C,
    3. Costa C,
    4. Michelon C,
    5. Oravec R,
    6. Ramos AB,
    7. et al.
    (2005) Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 51:24–29.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Fang Y,
    2. Shang QL,
    3. Liu JY,
    4. Li D,
    5. Xu WZ,
    6. Teng X,
    7. et al.
    (2009) Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 58:383–388.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Al-Ashgar HI,
    2. Khan MQ,
    3. Aljumah A,
    4. Sanai FM,
    5. Abdo AA,
    6. Dafalla MM,
    7. Fagih MA,
    8. Bzeizi KI
    (2012) Efficacy of peginterferon alpha-2a and predictors of response in HBeAg-negative, genotype D-naive patients. Hepatol Int 6:718–726.
    OpenUrl
  34. ↵
    1. Al-Ashqar HI,
    2. Al-Quaiz M,
    3. Dahab ST,
    4. Peedikayil MC
    (2013) Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia. Ann Saudi Med 33:119–123.
    OpenUrl
  35. ↵
    1. Alsohaibani F,
    2. Alturaif N,
    3. Abdulshakour A,
    4. Alghamdi S,
    5. Alshaibani A,
    6. Alashgar H,
    7. et al.
    (2015) Tenofovir in the Treatment of Naive and Refractory Chronic Hepatitis B: A Single Center Experience in Saudi Arabia. Saudi J Gastroenterol.
  36. ↵
    1. Candotti D,
    2. Grabarczyk P,
    3. Ghiazza P,
    4. Roig R,
    5. Casamitjana N,
    6. Iudicone P,
    7. et al.
    (2008) Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 49:537–547.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Rios-Ocampo WA,
    2. Cortes-Mancera F,
    3. Olarte JC,
    4. Soto A,
    5. Navas MC
    (2014) Occult hepatitis B virus infection among blood donors in Colombia. Virol J 11:206.
    OpenUrl
  38. ↵
    1. Liu CJ,
    2. Chen DS,
    3. Chen PJ
    (2006) Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 36:S33–S44.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Albertoni G,
    2. Castelo Girao MJ,
    3. Schor N
    (2014) Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. Int J Infect Dis 25:145–149.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section